Evidence map›Paper›PMID 41041311›Full record

ReviewFrontiers in immunology2025

Intracranial infections of

Congchen Tang, Chao Chen, Xiaoju Lv, Yi Xie, Li Xiong, Jiangchao Long, Hui Ye

Abstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Congchen Tang *Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Chao Chen *Department of Infectious Diseases, The Second People's Hospital of Yibin, Yibin, Sichuan, China.
Xiaoju LvCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Yi XieLaboratory Medicine Department, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Li XiongLaboratory Medicine Department, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Jiangchao LongIntensive Care Unit, Care Alliance Hetai Rehabilitation Hospital of Chengdu Tianfu New Area, Chengdu, Sichuan, China.
Hui YeCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Invasive candidiasis, most commonly caused by Case presentation: A 51-year-old male who was admitted to the hospital 3 years ago because of recurrent fever accompanied by headache. The causative factor remains elusive and symptomatic treatment yielded unsatisfactory results. Next-generation sequencing (NGS) of cerebrospinal fluid (CSF) identified the fungus as Conclusion: The c.175C>T (p. Arg59Trp) mutation is a novel CARD9 gene mutation and is probably damaging. Clinicians should consider immune impairment as a contributing factor in the management of fungal infections among non-HIV/AIDS patients. For such patients, conducting multiple CSF and blood cultures and employing new technologies such as NGS are advisable. Treatment of NTM and

Indexed as

Candida albicansCARD Signaling Adaptor ProteinsMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionAntifungal AgentsHumansMaleMiddle AgedMutationAntifungal AgentsCARD9 protein, humanCARD Signaling Adaptor ProteinsCandida albicansCARD9case reportimmune deficiencyMycobacterium intracellulare

Identifiers

PMID41041311
PMCPMC12484151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.